Vycor Medical Inc. (VYCO) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Vycor Medical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 199,046 316,450 971,367 1.21M 1.09M
Cost of Goods Sold (COGS) incl. D&A 59,477 105,538 386,231 508,420 504,358
COGS excluding D&A 22,482 48,737 155,925 156,920 128,165
Depreciation & Amortization Expense 36,995 56,801 230,306 351,500 376,193
Depreciation - 35,262 163,571 247,156 248,877
Amortization of Intangibles - 21,539 66,735 104,344 127,316
Gross Income 139,569 210,912 585,136 696,843 585,016
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - 1.93M 5.1M 3.54M 2.87M
Research & Development 4,761 15,208 115,665 126,042 53,451
Other SG&A - 1.92M 4.99M 3.41M 2.81M
Other Operating Expense - 0 0 0 0
Unusual Expense 50,725 212,230 110,032 (48,109) 0
EBIT after Unusual Expense (50,725) (212,230) (110,032) 48,109 0
Non Operating Income/Expense - 8 (23,718) 5,815 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) - 0 0 - -
Interest Expense 248,659 45,882 127,142 137,931 191,297
Gross Interest Expense 248,659 45,882 127,142 137,931 191,297
Interest Capitalized - 0 0 0 0
Pretax Income (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
Income Tax 0 2,248 0 0 0
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - 0 0 0 -
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
EPS (Basic) - (0.45) (0.90) (0.52) (0.39)
Basic Shares Outstanding - 4.42M 5.2M 5.64M 6.32M
EPS (Diluted) - (0.45) (0.90) (0.52) (0.39)
Diluted Shares Outstanding - 4.42M 5.2M 5.64M 6.32M
EBITDA (906,882) (1.67M) (4.29M) (2.49M) (1.91M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Vycor Medical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 199,046 316,450 971,367 1.21M 1.09M
Cost of Goods Sold (COGS) incl. D&A 59,477 105,538 386,231 508,420 504,358
COGS excluding D&A 22,482 48,737 155,925 156,920 128,165
Depreciation & Amortization Expense 36,995 56,801 230,306 351,500 376,193
Depreciation - 35,262 163,571 247,156 248,877
Amortization of Intangibles - 21,539 66,735 104,344 127,316
Gross Income 139,569 210,912 585,136 696,843 585,016
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - 1.93M 5.1M 3.54M 2.87M
Research & Development 4,761 15,208 115,665 126,042 53,451
Other SG&A - 1.92M 4.99M 3.41M 2.81M
Other Operating Expense - 0 0 0 0
Unusual Expense 50,725 212,230 110,032 (48,109) 0
EBIT after Unusual Expense (50,725) (212,230) (110,032) 48,109 0
Non Operating Income/Expense - 8 (23,718) 5,815 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) - 0 0 - -
Interest Expense 248,659 45,882 127,142 137,931 191,297
Gross Interest Expense 248,659 45,882 127,142 137,931 191,297
Interest Capitalized - 0 0 0 0
Pretax Income (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
Income Tax 0 2,248 0 0 0
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - 0 0 0 -
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.16M) (1.98M) (4.78M) (2.93M) (2.47M)
EPS (Basic) - (0.45) (0.90) (0.52) (0.39)
Basic Shares Outstanding - 4.42M 5.2M 5.64M 6.32M
EPS (Diluted) - (0.45) (0.90) (0.52) (0.39)
Diluted Shares Outstanding - 4.42M 5.2M 5.64M 6.32M
EBITDA (906,882) (1.67M) (4.29M) (2.49M) (1.91M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
